Search PubMed⌕ Search

Biomedical subjects

A Dulioust

Publications and source records attributed to A Dulioust.

21 records · Page 2Linked to original sources

Lipodystrophy in 685 HIV-1-treated patients: influence of antiretroviral treatment and immunovirological response.

PURPOSE: To describe the clinical features in HIV-1-infected patients treated with protease inhibitors (PIs) or not, and to determine factors related to occurrence of lipodystrophy (LD). METHOD: We performed a cross-sectional analysis of 685 treated HIV-1-infected patients that were routinely followed in 6 Paris hospital centers between January and May 1999. Demographic data, familial and personal vascular risk factors, history of antiretroviral treatment, HIV plasma viral load, CD4 cell count, and metabolic data were collected. Clinical examination was based on an assessment of changes in abdominal, dorso-cervical, and breast girth and wasting of the limbs, face, and skin as quoted by the clinician. RESULTS: The mean age at inclusion in the study was 38 years; 29.5% were women. At study assessment, 77.5% of patients were PI-treated and 22.5% had never received a PI. LD was observed in 403 (58.8%) patients, of whom 340 were currently receiving a PI and 63 had never received a PI. More than half of the lipodystrophic patients had a mixed form (53.9%), while 25.3% were classified as exclusive lipoatrophic and 20.8% as exclusive hypertrophic. In multivariate analysis, older age, duration of antiretroviral treatment (ART), antiretroviral combinations including stavudine, antiretroviral combinations including a PI, AIDS status, and a low HIV RNA were independently associated with occurrence of LD. CONCLUSION: LD is frequently observed in PI-treated patients, but it is also observed in patients receiving an ART regimen without PIs. Our study suggests different underlying mechanisms, because immunovirological response to treatment as well as certain therapies were linked to the occurrence of LD. This hypothesis would be best clarified in a large prospective cohort of naive patients.

Adult↗

Quantification of cytokine gene expression by competitive PCR using a colorimetric assay.

Competitive reverse transcription-polymerase chain reaction (RT-PCR) is a new technique allowing quantification of cytokine gene expression from either experimental or clinical samples. In this assay, a time-consuming step is the quantification of amplified products. To improve this step, we set up a colorimetric assay in which the amplified product from either the cDNA or the competitor can be reliably quantified. Using this approach, which can be completely automatized, up to 320 PCR products can be quantified each day. In this report, we describe the quantification of IL-10 mRNA molecules as compared to that of beta-actin mRNA molecules. The sensitivity of the quantification was 7.7 x 10(7) molecules for the amplified beta-actin cDNA and the amplified IL-10 cDNA, corresponding to approximately 9.6 pg amplified beta-actin cDNA and 11 pg amplified IL-10 cDNA, respectively. The intra-assay variation coefficient was < 12%. This technique can be readily extended to all cytokines, and it thus allows routine monitoring of cytokine gene expression, either from experimental samples or from clinical trials.

Actins↗